Prognostic value of subtype changes after neoadjuvant chemotherapy in primary breast cancer

被引：0
|
作者：
Matsumoto, Akiko [1 ]
Umemoto, Yasuko [1 ]
Yoshikawa, Mio [1 ]
Jinno, Hiromitsu [1 ]
机构：
[1] Teikyo Univ, Sch Med, Dept Surg, Tokyo, Japan
来源：
ANNALS OF ONCOLOGY | 2018年 / 29卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
O2 - 8 -5
引用
收藏
页数：1
相关论文
共 50 条
  • [31] The Prognostic Value of Axillary Staging Following Neoadjuvant Chemotherapy in Inflammatory Breast Cancer
    Monica M. Grova
    Paula D. Strassle
    Emma E. Navajas
    Kristalyn K. Gallagher
    David W. Ollila
    Stephanie M. Downs-Canner
    Philip M. Spanheimer
    Annals of Surgical Oncology, 2021, 28 : 2182 - 2190
  • [32] Prognostic value of metabolic response in breast cancer patients receiving neoadjuvant chemotherapy
    Cao, Maria D.
    Giskeodegard, Guro F.
    Bathen, Tone F.
    Sitter, Beathe
    Bofin, Anna
    Lonning, Per E.
    Lundgren, Steinar
    Gribbestad, Ingrid S.
    BMC CANCER, 2012, 12
  • [33] Androgen receptor expression in primary breast cancer and its predictive and prognostic value in patients treated with neoadjuvant chemotherapy
    Loibl, Sibylle
    Mueller, Berit Maria
    von Minckwitz, Gunter
    Schwabe, Michael
    Roller, Marc
    Darb-Esfahani, Silvia
    Ataseven, Beyhan
    du Bois, Andreas
    Fissler-Eckhoff, Annette
    Gerber, Bernd
    Kulmer, Uwe
    Alles, Jens-Uwe
    Mehta, Keyur
    Denkert, Carsten
    BREAST CANCER RESEARCH AND TREATMENT, 2011, 130 (02) : 477 - 487
  • [34] Androgen receptor expression in primary breast cancer and its predictive and prognostic value in patients treated with neoadjuvant chemotherapy
    Sibylle Loibl
    Berit Maria Müller
    Gunter von Minckwitz
    Michael Schwabe
    Marc Roller
    Silvia Darb-Esfahani
    Beyhan Ataseven
    Andreas du Bois
    Annette Fissler-Eckhoff
    Bernd Gerber
    Uwe Kulmer
    Jens-Uwe Alles
    Keyur Mehta
    Carsten Denkert
    Breast Cancer Research and Treatment, 2011, 130
  • [35] Changes in and prognostic value of hormone receptor status in a series of operable breast cancer patients treated with neoadjuvant chemotherapy
    Tacca, Olivier
    Penault-Llorca, Frederique
    Abrial, Catherine
    Mouret-Reynier, Marie-Ange
    Raoelfils, Ines
    Durando, Xavier
    Achard, Jean-Louis
    Gimbergues, Pierre
    Cure, Herve
    Chollet, Phillipe
    ONCOLOGIST, 2007, 12 (06): : 636 - 643
  • [36] Predictive value of axillary nodal imaging by magnetic resonance imaging based on breast cancer subtype after neoadjuvant chemotherapy
    Steiman, Jennifer
    Soran, Atilla
    McAuliffe, Priscilla
    Diego, Emilia
    Bonaventura, Marguerite
    Johnson, Ronald
    Ahrendt, Gretchen
    McGuire, Kandace
    JOURNAL OF SURGICAL RESEARCH, 2016, 204 (01) : 237 - 241
  • [37] Prognostic value of residual cancer burden after neoadjuvant taxane-anthracycline chemotherapy in phenotypic subsets of breast cancer
    Hubbard, R.
    Peintinger, F.
    Liedtke, C.
    Hatzis, C.
    Kuerer, H. M.
    Valero, V.
    Buzdar, A. U.
    Hortobagyi, G. N.
    Pusztai, L.
    Symmans, W. F.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [38] MRI Performance in Detecting pCR After Neoadjuvant Chemotherapy by Molecular Subtype of Breast Cancer
    Nancy Yu
    Vivian W. Y. Leung
    Sarkis Meterissian
    World Journal of Surgery, 2019, 43 : 2254 - 2261
  • [39] Comparison of Protein Expression and Molecular Subtype in Breast Cancer before and after Neoadjuvant Chemotherapy
    Lee, H-C
    Seol, H.
    Ko, H.
    Park, I. A.
    LABORATORY INVESTIGATION, 2011, 91 : 50A - 50A
  • [40] The Effect of Postmastectomy Radiotherapy on Breast Cancer Patients After Neoadjuvant Chemotherapy by Molecular Subtype
    Ma, Jia-Chun
    Zhong, Xiang-Rong
    Luo, Ting
    Xiang, Zhong-Zheng
    Li, Jia-Yuan
    Luo, Chuanxu
    Yan, Xi
    He, Ping
    Tian, Ting-Lun
    Liu, Fang
    Liu, Lei
    Zheng, Hong
    ANNALS OF SURGICAL ONCOLOGY, 2021, 28 (09) : 5084 - 5095
12345